Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $92,890 | 19 | 57.9% |
| Travel and Lodging | $44,472 | 24 | 27.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,570 | 3 | 14.1% |
| Food and Beverage | $571.08 | 13 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $95,967 | 28 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $29,172 | 20 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $21,957 | 8 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $9,997 | 2 | $0 (2017) |
| The Medicines Company | $3,410 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $3,627 | 1 | Amgen Inc. ($3,627) |
| 2019 | $34,124 | 7 | Amgen Inc. ($34,124) |
| 2018 | $27,429 | 6 | Amgen Inc. ($14,311) |
| 2017 | $95,323 | 45 | Amgen Inc. ($43,905) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2020 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $3,627.29 | General |
| Category: Cardiology | ||||||
| 07/08/2019 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $4,529.97 | General |
| Category: Cardiology | ||||||
| 04/23/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $36.11 | General |
| 04/23/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $4.10 | General |
| 04/23/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $2.80 | General |
| 04/16/2019 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,000.00 | General |
| Category: Cardiology | ||||||
| 04/16/2019 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $9,443.44 | General |
| Category: Cardiology | ||||||
| 01/10/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $6,107.54 | General |
| 12/20/2018 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 08/25/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $11.04 | General |
| 04/30/2018 | The Medicines Company | — | Consulting Fee | Cash or cash equivalent | $3,409.52 | General |
| 01/29/2018 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Consulting Fee | Cash or cash equivalent | $9,300.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 01/24/2018 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $9,900.00 | General |
| Category: Cardiology | ||||||
| 01/05/2018 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $408.43 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/20/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $112.40 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/15/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| 12/15/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $207.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/15/2017 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 12/12/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $217.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/12/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $109.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/11/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $7,690.00 | General |
| 12/07/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $11,562.66 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/07/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $40.25 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/01/2017 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| Category: Cardiology | ||||||
| 12/01/2017 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: Cardiology | ||||||
About Dr. Brian Ference, MD
Dr. Brian Ference, MD is a Cardiovascular Disease healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255394276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Ference, MD has received a total of $160,503 in payments from pharmaceutical and medical device companies, with $3,627 received in 2020. These payments were reported across 59 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($92,890).
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Detroit, MI
- Active Since 04/10/2006
- Last Updated 01/27/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255394276
Products in Payments
- Repatha (Biological) $68,649
- PRALUENT ALIROCUMAB INJECTION (Biological) $21,957
- NO PRODUCT DISCUSSED (Drug) $7,690
- PRALUENT (Drug) $2,307
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Detroit
Dr. Tamam Mohamad
Cardiovascular Disease — Payments: $1.4M
Wayne Douglas Weaver, M.d, M.D
Cardiovascular Disease — Payments: $360,582
Dr. Brian O'neill, M.d, M.D
Cardiovascular Disease — Payments: $182,193
David Lanfear, M.d, M.D
Cardiovascular Disease — Payments: $160,449
Dr. Mahir Elder, Md, MD
Cardiovascular Disease — Payments: $132,144
Dr. Zaher Hakim, M.d, M.D
Cardiovascular Disease — Payments: $93,632